Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Rheumatoid arthritis

New EULAR guidelines for RA: a job well done

Nature Reviews Rheumatology volume 10, pages 6–8 (2014)Cite this article

Subjects

The 2013 update of the EULAR recommendations for the treatment of rheumatoid arthritis has evolved in several domains, and has, for the first time, elevated non-TNF-inhibitor biologic agents to the same status as TNF inhibitors. These transparently derived and scholarly recommendations will contribute to the evolving dialogue on the proper use of these agents.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2013-204573.

  2. Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann. Rheum. Dis. 69, 964–975 (2010).

    CAS  PubMed  Google Scholar 

  3. Smolen, J. S. et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann. Rheum. Dis. 69, 631–637 (2010).

    Article  PubMed  Google Scholar 

  4. Klarenbeek, N. B. et al. The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study. Ann. Rheum. Dis. 70, 1039–1046 (2011).

    Article  PubMed  Google Scholar 

  5. O'Dell, J. R. et al. Therapies for active rheumatoid arthritis after methotrexate failure. N. Engl. J. Med. 369, 307–318 (2013).

    Article  CAS  PubMed  Google Scholar 

  6. Singh, J. A. et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res. 64, 625–639 (2012).

    Article  CAS  Google Scholar 

  7. Greenberg, J. D. et al. Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann. Rheum. Dis. 70, 576–582 (2011).

    Article  PubMed  Google Scholar 

  8. Van Sijl, A. M. et al. Confounding by indication distorts the relationship between steroid use and cardiovascular disease in rheumatoid arthritis. Arthritis Rheum. 65, S1007–S1008 (2013).

    Google Scholar 

  9. Choi, H. K. et al. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359, 1173–1177 (2002).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Albany Medical College, The Centre for Rheumatology, 1367 Washington Avenue, Albany, 12206, NY, USA

    Joel M. Kremer

Authors
  1. Joel M. Kremer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joel M. Kremer.

Ethics declarations

Competing interests

J. M. Kremer declares that he has received grant support for research from Abbvie, Amgen, BMS, Genentech, Janssen, Novo-Nordisk, Pfizer and UCB, and has consulted for Abbvie, Amgen, BMS, Genentech, Pfizer and UCB.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kremer, J. New EULAR guidelines for RA: a job well done. Nat Rev Rheumatol 10, 6–8 (2014). https://doi.org/10.1038/nrrheum.2013.188

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2013.188

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing